The Pharmacogenomics of Anti-Hypertensive Therapy

The Pharmacogenomics of Anti-Hypertensive Therapy

Hypertension is a major public health problem, but measures to reduce blood pressure and thus cardiovascular risk are complicated by the high prevalence of treatment resistance, despite the availability of multiple drugs. Drug side-effects contribute considerably to suboptimal blood pressure control...

Full description

Bibliographic Details
Main Authors: Sandosh Padmanabhan, Laura Paul, Anna F. Dominczak
Format: Article
Language:English
Published: MDPI AG 2010-06-01
Series:Pharmaceuticals
Subjects:
hypertension
pharmacogenetics
pharmacogenomics
beta-blockers
ACE inhibitors
angiotensin receptor blockers
antihypertensive
calcium channel blockers
thiazide diuretics
Online Access:http://www.mdpi.com/1424-8247/3/6/1779/

Internet

http://www.mdpi.com/1424-8247/3/6/1779/

Similar Items